Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.
作者信息
Takaya S, Bronsther O, Abu-Elmagd K, Ramos H, Fung J J, Todo S, Starzl T E
机构信息
Pittsburgh Transplant Institute, Pennsylvania.
出版信息
Transplant Proc. 1993 Jun;25(3):2381-5.
Abstract
摘要
相似文献
1
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.前列腺素E1在接受FK 506治疗的交叉配型阴性肝移植受者中的应用。
Transplant Proc. 1993 Jun;25(3):2381-5.
2
FK 506 treatment of intractable rejection after liver transplantation.FK506治疗肝移植后难治性排斥反应
Transplant Proc. 1993 Aug;25(4):2686-7.
3
FK 506 as treatment of late acute rejection in liver transplant patients.FK506用于肝移植患者晚期急性排斥反应的治疗。
Transplant Proc. 1995 Feb;27(1):1105-6.
4
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
Transplant Proc. 1996 Apr;28(2):1011-3.
5
Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation.T淋巴细胞毒性交叉配型在肝移植及肝肾联合移植中的意义
Transplantation. 2001 Apr 27;71(8):1163-8. doi: 10.1097/00007890-200104270-00025.
6
Experience in one center of combined kidney and liver transplantation in 22 patients: incidence of graft rejection and long-term graft outcome.一家中心22例肝肾联合移植的经验：移植排斥反应发生率及移植长期预后
Transplant Proc. 1997 Feb-Mar;29(1-2):243-4. doi: 10.1016/s0041-1345(96)00080-2.
7
Impact of immunosuppression in liver transplantation across a positive crossmatch.免疫抑制在阳性交叉配型肝移植中的影响。
Transplant Proc. 1998 Jun;30(4):1466-7. doi: 10.1016/s0041-1345(98)00318-2.
8
9
Incidence of acute rejection in African-American liver transplant recipients.非裔美国肝移植受者急性排斥反应的发生率。
Transplant Proc. 1998 Jun;30(4):1492-4. doi: 10.1016/s0041-1345(98)00330-3.
引用本文的文献
1
Prostaglandins for adult liver transplanted recipients.前列腺素类药物在成人肝移植受者中的应用。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD006006. doi: 10.1002/14651858.CD006006.pub3.
2
The Future of Xenotransplantation.异种移植的未来。
Ann Surg. 1992 Oct 1;216(4):3-10.
3
A cost analysis of alprostadil in liver transplantation.前列地尔在肝移植中的成本分析。
Pharmacoeconomics. 1996 Jun;9(6):517-24. doi: 10.2165/00019053-199609060-00006.
4
Baboon-to-human liver transplantation.狒狒到人类的肝脏移植。
Lancet. 1993 Jan 9;341(8837):65-71. doi: 10.1016/0140-6736(93)92553-6.
5
The biological basis of and strategies for clinical xenotransplantation.临床异种移植的生物学基础与策略
Immunol Rev. 1994 Oct;141:213-44. doi: 10.1111/j.1600-065x.1994.tb00879.x.
6
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.临床肝移植后应用前列腺素E1减少原发性无功能的发生
Transplant Proc. 1995 Apr;27(2):1862-7.
本文引用的文献
1
99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A.用环孢素A治疗的肝移植受者的99m锝-二乙三胺五乙酸和131碘-马尿酸盐检查结果
Radiology. 1982 Jan;142(1):199-202. doi: 10.1148/radiology.142.1.7031760.
2
Prostaglandin E inhibits the production of human interleukin 2.前列腺素E抑制人白细胞介素2的产生。
J Exp Med. 1982 Mar 1;155(3):943-8. doi: 10.1084/jem.155.3.943.
3
Prostaglandins modulate macrophage Ia expression.前列腺素调节巨噬细胞Ia抗原的表达。
Nature. 1982 Sep 9;299(5879):163-5. doi: 10.1038/299163a0.
4
Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins.
Clin Nephrol. 1986;25 Suppl 1:S89-94.
5
PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats.
Clin Nephrol. 1986;25 Suppl 1:S95-9.
6
Selective enhancement of thromboxane in macrophages and kidneys in cyclosporine-induced nephrotoxicity. Dietary protection by fish oil.
Transplantation. 1988 Jan;45(1):153-6. doi: 10.1097/00007890-198801000-00033.
7
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response.通过调节炎症介质反应延长猪到犬肾异种移植的存活时间。
Ann Surg. 1987 Oct;206(4):482-95. doi: 10.1097/00000658-198710000-00009.
8
Infections after liver transplantation. An analysis of 101 consecutive cases.肝移植术后感染。101例连续病例分析。
Medicine (Baltimore). 1988 Mar;67(2):132-43. doi: 10.1097/00005792-198803000-00006.
9
Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate.前列腺素E2对T淋巴细胞激活作用的分析。肿瘤促进剂12-O-十四酰佛波醇-13-乙酸酯消除前列腺素E2的抑制作用。
J Clin Invest. 1987 Aug;80(2):333-40. doi: 10.1172/JCI113077.
10
Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.前列腺素E2可抑制克隆化T细胞杂交瘤的激活。
J Immunol. 1985 Apr;134(4):2645-50.
Zotero 插件